These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16322789)

  • 1. New ways in which GLP-1 can regulate glucose homeostasis.
    D'Alessio DA; Sandoval DA; Seeley RJ
    J Clin Invest; 2005 Dec; 115(12):3406-8. PubMed ID: 16322789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central GLP-1 actions on energy metabolism.
    Velásquez DA; Beiroa D; Vázquez MJ; Romero A; López M; Diéguez C; Nogueiras R
    Vitam Horm; 2010; 84():303-17. PubMed ID: 21094905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of sub-chronic activation of glucagon-like peptide-1 (GLP-1) receptors on deterioration of glucose homeostasis and insulin secretion in aging mice.
    Irwin N; McClean PL; Harriott P; Flatt PR
    Exp Gerontol; 2007 Apr; 42(4):296-300. PubMed ID: 17184947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.
    Sandoval DA; D'Alessio DA
    Physiol Rev; 2015 Apr; 95(2):513-48. PubMed ID: 25834231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ
    Dan Med Bull; 2010 Sep; 57(9):B4181. PubMed ID: 20816021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL; Huang Q; Cao X; Drucker DJ
    Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
    Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
    J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1, glucose homeostasis and diabetes.
    Holst JJ; Deacon CF; Vilsbøll T; Krarup T; Madsbad S
    Trends Mol Med; 2008 Apr; 14(4):161-8. PubMed ID: 18353723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1: glucose homeostasis and beyond.
    Cho YM; Fujita Y; Kieffer TJ
    Annu Rev Physiol; 2014; 76():535-59. PubMed ID: 24245943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preproglucagon Products and Their Respective Roles Regulating Insulin Secretion.
    Bethea M; Bozadjieva-Kramer N; Sandoval DA
    Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34318874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
    D'Alessio DA; Vahl TP
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus.
    De León DD; Crutchlow MF; Ham JY; Stoffers DA
    Int J Biochem Cell Biol; 2006; 38(5-6):845-59. PubMed ID: 16202636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
    Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
    Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiology of glucagon-like peptide 1.
    Holst JJ
    Physiol Rev; 2007 Oct; 87(4):1409-39. PubMed ID: 17928588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic actions and therapeutic potential of the proglucagon-derived peptides.
    Drucker DJ
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):22-31. PubMed ID: 16929363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
    Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Tanaka I
    Metabolism; 2003 Jan; 52(1):81-6. PubMed ID: 12524666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.